Gijs Van De Wetering
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A global model for symptomatic obstructive hypertrophic cardiomyopathy to assess the cost-effectiveness of mavacamten: results from a Dutch societal perspective.
Journal: Journal of medical economics
Published: June 08, 2026
Transforming PAH care in Italy: a clinical and economic evaluation of sotatercept add-on therapy.
Journal: Journal of medical economics
Published: December 17, 2025
A cost-effectiveness analysis of deucravacitinib vs. apremilast in moderate-to-severe psoriasis patients in Japan.
Journal: Journal of medical economics
Published: June 05, 2025
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.
Journal: Advances in therapy
Published: March 14, 2025
Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis.
Journal: PharmacoEconomics - open
Published: January 28, 2025
Cost-effectiveness of nivolumab and ipilimumab versus pembrolizumab and axitinib in advanced renal cell carcinoma with intermediate or poor prognostic risk: a Brazilian private healthcare system perspective.
Journal: Journal of medical economics
Published: August 26, 2023
A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada.
Journal: PharmacoEconomics - open
Published: September 26, 2022
Modification of treatment-sequence model with a customizable number of treatments to better reflect contemporary and future clinical practice in moderate to severe psoriasis.
Journal: Journal of medical economics
Published: March 17, 2022
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: October 29, 2021
Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain.
Journal: Journal of medical economics
Published: June 11, 2021
Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE.
Journal: The British journal of dermatology
Published: December 01, 2017
Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data.
Journal: Applied health economics and health policy
Published: August 24, 2016
Last Updated: 09/26/2026